Top-News

Bio-Techne Aktie News

Aktie
WKN:  A12ENG ISIN:  US09073M1045 US-Symbol:  TECH Branche:  Biotechnologie Land:  USA
53,00 €
+0,00 €
0,00%
10:44:01 Uhr
Depot/Watchlist
Marktkapitalisierung *
8,01 Mrd. €
Streubesitz
-
KGV
109,47
Dividende
0,080 $
Dividendenrendite
0,13%
neu: Nachhaltigkeits-Score
46 %
Index-Zuordnung
S&P 500

Bio-Techne News

26.03.25 - PR Newswire
Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany
Bio-​Techne Announces New Customer Experience Centre in Düsseldorf, Germany PR Newswire
24.03.25 - PR Newswire
Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
Bio-​Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting PR Newswire
10.03.25 - PR Newswire
Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System
Bio-​Techne Begins Shipping Leo - A Next Generation High-​Throughput Simple Western System PR Newswire
03.03.25 - PR Newswire
Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
Bio-​Techne Launches New Panel Resolving Hard-​to-Decipher Carrier Screening Genes PR Newswire
27.02.25 - PR Newswire
Bio-Techne to Present at Investor Conferences
Bio-​Techne to Present at Investor Conferences PR Newswire
20.02.25 - PR Newswire
Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
Bio-​Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology PR Newswire
18.02.25 - PR Newswire
Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
Bio-​Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System PR Newswire
05.02.25 - PR Newswire
Bio-Techne Declares Dividend
Bio-​Techne Declares Dividend PR Newswire
05.02.25 - PR Newswire
Bio-Techne Releases Second Quarter Fiscal 2025 Results
Bio-​Techne Releases Second Quarter Fiscal 2025 Results PR Newswire
04.02.25 - PR Newswire
Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
Bio-​Techne Appoints Dr. Amy E. Herr to Board of Directors PR Newswire
21.01.25 - PR Newswire
Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results
Bio-​Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results PR Newswire
21.01.25 - PR Newswire
ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio
ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio PR Newswire
10.01.25 - PR Newswire
Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
Bio-​Techne Expands R&D Systems AI-​Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine PR Newswire
08.01.25 - PR Newswire
BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
BIO-​TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025 PR Newswire
08.01.25 - PR Newswire
ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics
ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics PR Newswire
07.01.25 - PR Newswire
BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
BIO-​TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC PR Newswire
20.12.24 - PR Newswire
BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
BIO-​TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PR Newswire
19.12.24 - PR Newswire
BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
BIO-​TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-​MARKETING AND CO-​PROMOTION AGREEMENT PR Newswire
18.12.24 - PR Newswire
ScaleReady awards a G-Rex® Grant to Moonlight Bio
ScaleReady awards a G-Rex® Grant to Moonlight Bio PR Newswire
12.12.24 - PR Newswire
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
BIO-​TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY PR Newswire

Newssuche

Videos

newspaper
05.12.25 +1,73%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »